List of Salonpas drug patents

Salonpas is owned by Hisamitsu Pharm Co.

Salonpas contains Menthol; Methyl Salicylate.

Salonpas has a total of 2 drug patents out of which 0 drug patents have expired.

Salonpas was authorised for market use on 20 February, 2008.

Salonpas is available in patch;topical dosage forms.

The generics of Salonpas are possible to be released after 03 January, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9233184 HISAMITSU PHARM CO Adhesive preparation
Aug, 2027

(4 years from now)

US8809615 HISAMITSU PHARM CO Adhesive preparation
Jan, 2030

(6 years from now)

Drugs and Companies using MENTHOL; METHYL SALICYLATE ingredient

Market Authorisation Date: 20 February, 2008

Treatment: NA

Dosage: PATCH;TOPICAL

More Information on Dosage

SALONPAS family patents

4

United States

3

Japan

1

Taiwan, Province of China

1

Hungary

1

Korea, Republic of

1

New Zealand

1

Singapore

1

Australia

1

Malaysia

1

Canada

1

Russia

1

Mexico

1

Spain

1

China

1

Brazil

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in